Global Organ Transplant Immunosuppressant Drugs Market to Decline at -5.0% CAGR till 2023 due to Demand and Supply Imbal

1. http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.htmlhttp://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html Global Organ Transplant Immunosuppressant Drugs Market Research and Development – Trends and Forecast

2. Report Description: • The global organ transplant immunosuppressant drugs market will decline at a CAGR of -5.0% during the forecast period from 2015 to 2023. In 2014, the global organ transplant immunosuppressant drugs market was estimated at US$5.1 bn and by 2023, the market will shrink to a value of US$3.2 bn. • The global organ transplant immunosuppressant drugs market is restrained by several factors. Factors such as the high cost of procedure and inadequate insurance coverage are projected to suppress the global organ transplant immunosuppressant drugs market in the coming few years. In addition to this, the advent of stem cells and lack of donor organs will also constrain the global organ transplant immunosuppressant drugs market in the foreseeable future. Nevertheless, the global market for organ transplant immunosuppressant drugs will benefit from the growing incidence of chronic diseases resulting in organ failure and disabilities. http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

3. By drug class, the global organ transplant immunosuppressant drugs market is divided into steroids, antibodies, mTOR inhibitors, antiproliferative agents, calcineurin inhibitors. The global organ transplant immunosuppressant drugs market was led by the calcineurin inhibitors sector in 2014. This sector was estimated at US$2.3 bn in 2014. The majority of kidney transplant recipients are prescribed tacrolimus to maintain immunosuppressive regimen due to its higher potency and lower rejection nephrotoxicity as compared to cyclosporine. • Geography-wise, the global organ transplant immunosuppressant drugs market is segmented into Latin America, Asia Pacific, Europe, North America, and Rest of the World. The WHO states that in 2013, the U.S. was the most lucrative country for organ transplantation. The North American region leads the global organ transplant immunosuppressant drugs market due to technological improvements, enhanced surgical techniques, enhanced immunosuppressive drugs, and rising success rate of organ transfer procedures. http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

4. Global Organ Transplant Immunosuppressant Drugs, by Drug Class • Calcineurin Inhibitors • Tacrolimus • Cyclosporine • Antiproliferative Agents • MycophenolateMofetil • Mycophenolate Sodium • Azathioprine http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

5. Global Organ Transplant Immunosuppressant Drugs, by Geography • North America • U.S. • Canada • Europe • U.K. • Germany • Rest of Europe http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

6. About Transparency Market Research : Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations. http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html

7. Contact Us: Mr. Sudip S.Transparency Market Research90 State Street,Suite 700,AlbanyNY – 12207United StatesTel: +1-518-618-1030USA – Canada Toll Free 866-552-3453Email: sales@transparencymarketresearch.comWebsite: http://www.transparencymarketresearch.com/ http://www.transparencymarketresearch.com/organ-transplant-immunosuppressant-drugs.html